Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors
…, Z Greff, A Sipos, Z Varga, R Székely…
Index: Nemeth, Gabor; Greff, Zoltan; Sipos, Anna; Varga, Zoltan; Szekely, Rita; Sebestyen, Monika; Jaszay, Zsuzsa; Beni, Szabolcs; Nemes, Zoltan; Pirat, Jean-Luc; Volle, Jean-Noel; Virieux, David; Gyuris, Agnes; Kelemenics, Katalin; Ay, Eva; Minarovits, Janos; Szathmary, Susan; Keri, Gyoergy; Orfi, Laszlo Journal of Medicinal Chemistry, 2014 , vol. 57, # 10 p. 3939 - 3965
Full Text: HTML
Citation Number: 21
Abstract
Although there is a significant effort in the design of a selective CDK9/CycT1 inhibitor, no compound has been proven to be a specific inhibitor of this kinase so far. The aim of this research was to develop novel and selective phosphorus containing CDK9/CycT1 inhibitors. Molecules bearing phosphonamidate, phosphonate, and phosphinate moieties were synthesized. Prepared compounds were evaluated in an enzymatic CDK9/CycT1 assay. ...
Related Articles:
Novel pyrazolo [1, 5-a] pyridines as PI3K inhibitors: variation of the central linker group
[Kendall, Jackie D.; Marshall, Andrew J.; Giddens, Anna C.; Tsang, Kit Yee; Boyd, Maruta; Frederick, Raphael; Lill, Claire L.; Lee, Woo-Jeong; Kolekar, Sharada; Chao, Mindy; Malik, Alisha; Yu, Shuqiao; Chaussade, Claire; Buchanan, Christina M.; Rewcastle, Gordon W.; Baguley, Bruce C.; Flanagan, Jack U.; Denny, William A.; Shepherd, Peter R. MedChemComm, 2014 , vol. 5, # 1 p. 41 - 46]